Social Media Site Could Help FDA Track Adverse Events
Executive Summary
FDA-pharma partnership could improve data quality and increase use as industry continues to struggle to incorporate social media into pharmacovigilance.
You may also be interested in...
PDUFA VI: Breakthrough Issues Among FDA Priorities
Agency and industry also decide to drop research into using social media to enhance post-market safety monitoring.
PDUFA VI: FDA Proposes Expanding Sentinel, Real-World Safety Data Sources
Growth of post-market surveillance system also may require more resources.
To Improve Adverse Event Tracking, FDA Could Google It
Teleconference between Google and FDA signals the internet search giant could have a way to improve adverse-event detection. The agency calls the talk “a high-level, general discussion” of Google’s capabilities.